Literature DB >> 16202666

Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.

Amanda L Brennan1, Khin M Gyi, David M Wood, Margaret E Hodson, Duncan M Geddes, Emma H Baker.   

Abstract

BACKGROUND: HbA(1c) is recommended for monitoring glycaemic control in people with cystic fibrosis-related diabetes (CFRD). However the relationship between HbA(1c) and mean plasma glucose concentration (MPG) has not been established in CFRD, as in other forms of diabetes mellitus.
METHODS: 20 people (13 male, 29.7+/-8.8 years, 10 CFRD) with cystic fibrosis (CF) underwent HbA(1c) measurement and 48 h continuous glucose monitoring for estimation of MPG. The relationship between HbA(1c) and MPG was established and compared to the reported relationship for type 1 diabetes.
RESULTS: HbA(1c) was strongly correlated with MPG (R(2)=0.888, p<0.0001) in CF. The relationship of MPG to HbA(1c) was described by the equation MPG=(1.47xHbA(1c))-1.15, giving a 1.47 mmol L(-1) change in MPG per 1% change in HbA(1c). This equation predicts that MPG in people with CF and HbA(1c) <7.0% will be similar to MPG in people with type 1 diabetes who achieve the same HbA(1c) target.
CONCLUSIONS: These results imply that HbA(1c)<7.0% will predict good blood glucose control in CF as in type 1 diabetes. However, although HbA(1c) predicts complications in type 1 diabetes, further studies are required to establish the relationship between HbA(1c) and diabetic complications in people with CFRD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202666     DOI: 10.1016/j.jcf.2005.09.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  10 in total

Review 1.  Update in cystic fibrosis 2005.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2006-05-01       Impact factor: 21.405

2.  Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.

Authors:  Christine L Chan; Emma Hope; Jessica Thurston; Timothy Vigers; Laura Pyle; Philip S Zeitler; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2018-04-19       Impact factor: 19.112

3.  Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

Authors:  Kevin J Scully; Jordan S Sherwood; Kimberly Martin; Melanie Ruazol; Peter Marchetti; Mary Larkin; Hui Zheng; Gregory S Sawicki; Ahmet Uluer; Isabel Neuringer; Lael M Yonker; Leonard Sicilian; Deborah J Wexler; Melissa S Putman
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 4.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

5.  A Comparison of HbA1c and Fasting Blood Sugar Tests in General Population.

Authors:  Zahra Ghazanfari; Ali Akbar Haghdoost; Sakineh Mohammad Alizadeh; Jamileh Atapour; Farzaneh Zolala
Journal:  Int J Prev Med       Date:  2010

6.  Hyperglycemia and death in cystic fibrosis-related diabetes.

Authors:  Amanda I Adler; Brian Shine; Charles Haworth; Lalantha Leelarathna; Diana Bilton
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

7.  Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.

Authors:  Swapnil Khare; Marisa Desimone; Nader Kasim; Christine L Chan
Journal:  J Clin Transl Endocrinol       Date:  2021-12-07

Review 8.  Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review.

Authors:  Shanal Kumar; Michael Pallin; Georgia Soldatos; Helena Teede
Journal:  J Clin Transl Endocrinol       Date:  2022-09-27

9.  Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children.

Authors:  Chirag Kapadia; Philip Zeitler
Journal:  Int J Pediatr Endocrinol       Date:  2012-12-20

Review 10.  A Practical Approach to Glucose Abnormalities in Cystic Fibrosis.

Authors:  Gregory C Jones; Christopher A R Sainsbury
Journal:  Diabetes Ther       Date:  2016-10-17       Impact factor: 2.945

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.